PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Pantothenol→

Pantothenol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
81-13-0
Molecular formula
C9H19NO4
Molecular weight
205.25 g/mol
Drug class
Provitamin B5dexpanthenol-related skin-conditioning and wound-care agent
Mechanism of action
An alcoholic analogue of D-pantothenic acid that is converted to pantothenic acid and contributes to coenzyme A synthesis. Topical dexpanthenol-containing preparations support skin hydration and epithelial repair; the exact mechanism in topical use is not fully established.
Indications / reported uses
  • Topical use to support skin-barrier recovery and minor wound healing in authorised creams and ointments.
  • Dexpanthenol-containing preparations are also used for selected mucosal and gastrointestinal indications in some jurisdictions.

Sources: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol · https://pubchem.ncbi.nlm.nih.gov/#query=pantothenol · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Pantothenol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pantothenol Permitted Daily Exposure (PDE) report (the Pantothenol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pantothenol Occupational Exposure Limit (OEL) report (the Pantothenol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.